Crystalline forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide
TW202629561APending Publication Date: 2026-07-16AGIOS PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115110557
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-06-29
- Filing Date
- 2018-11-21
- Publication Date
- 2026-07-16
Abstract
Provided herein are amorphous and crystalline hemisulfate salt forms of the formula. . Also provided are pharmaceutical compositions comprising the amorphous and crystalline hemisulfate salt forms, methods for their manufacture, and uses thereof for treating conditions associated with pyruvate kinase such as e.g., pyruvate kinase deficiency.
Need to check novelty before this filing date? Find Prior Art